Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 4, 2009, Pages 664-670

  van der Heijden, J ^a   de Beer, Y ^a   Hoogtanders, K ^a   Christiaans, M ^a   de Jong, G J ^b   Neef, C ^a   Stolk, L ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

DBS; Dried blood spot; Everolimus; LC MS MS; TDM

Indexed keywords

AMMONIUM ACETATE; EVEROLIMUS; FORMIC ACID; NORRAPAMYCIN; PLASMA PROTEIN; RAPAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG MONITORING; ELECTROSPRAY MASS SPECTROMETRY; FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; TANDEM MASS SPECTROMETRY;

BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; REPRODUCIBILITY OF RESULTS; SIROLIMUS; SPECIMEN HANDLING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TEMPERATURE; TIME FACTORS;

EID: 67849128908     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.11.021     Document Type: Article

References (15)

1. Hoogtanders K., van der Heijden J., Christiaans M., Edelbroek P., van Hooff J., and Stolk L. J. Pharm. Biomed. Anal. 44 (2006) 658-664
2. Allanson A., Cotton M., Tettey J., et al. J. Pharm. Biomed. Anal. 44 (2007) 963-969
3. Kirchner G.I., Meier-Wiedenbach I., and Manns M.P. Clin. Pharmacokinet. 43 (2004) 83-95
4. Hoogtanders K., van der Heijden J., Christiaans M., van de Plas A., van Hooff J., and Stolk L. Transplantation 83 (2007) 237-238
5. Bergquist Y., Hjelm E., and Rombo L. Ther. Drug Monit. 9 (1987) 203-207
6. Chace D.H., Kalas T.A., and Naylor E.W. Clin. Chem. 49 (2003) 1797-1817
7. Koal T., Burhenne H., Romling R., et al. Rapid Commun. Mass Spectrom. 19 (2005) 2995-3001
8. ter Heine R., Rosing H., van Gorp E.C.M., Mulder J.W., van der Steeg W.A., Beijnen J.H., and Huitema A.D.R. J. Chromatogr. B 867 (2008) 205-212
9. Malm M., Lindegardh N., and Bergquist Y. J. Chromatogr. B 809 (2004) 43-49
10. Bergquist Y., Funding L., and Kaneko A. J. Chromatogr. B 719 (1998) 141-149
11. AbuRuz S., Millership J., and McElnay J. J. Chromatogr. B 832 (2006) 202-207
12. Blessborn D., Romsing S., Annerberg A., Sundquist D., Bjorkman A., Lindegarh N., and Bergquist Y. J. Pharm. Biomed. Anal. 45 (2007) 282-287
13. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services FDA, Rockville, May 2001.
14. Matuszewski B., Constanzer M., and Chavez-Eng C. Anal. Chem. 75 (2003) 3019-3030
15. Taylor P.J., Franklin M.E., Graham K.S., and Pillans P.I. J. Chromatogr. B 848 (2007) 208-214